Germany · Series D startup
6 rounds we have observed, with the 15 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$184Mraised across 6 rounds since 2004, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by finsmes.com
Wellington Partners
dievini Hopp Biotech HoldingReported by immatics.com
Reported by tornado-insider.com
Wellington Partners
Grazia Equity
EMBL Ventures
Merifin Capital
VINCI CAPITAL
L-BankFrom a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Wellington Partnersdievini Hopp Biotech HoldingAT Impf
3i GroupGrazia EquityEMBL VenturesMerifin CapitalVINCI CAPITALL-Bank
KfWMissing a round, or an investor who was in one? Tell us.
immatics biotechnologies's investors include Wellington Partners, dievini Hopp Biotech Holding, AT Impf, 3i Group and Grazia Equity, and 10 more on record.
immatics biotechnologies has raised $184M across 6 rounds since 2004.
immatics biotechnologies's most recent round was a Series D of $30M in Jul 2014.
immatics biotechnologies's largest round on record is $71M (Series C), in Sept 2010.
immatics biotechnologies's first round on record, in Feb 2004, was backed by 3i Group, Wellington Partners and Grazia Equity and 4 others.
immatics biotechnologies's latest named round is a Series D, in Jul 2014.
immatics biotechnologies is based in Germany.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Germany · 
